Alan M. Rapoport

8.7k total citations
200 papers, 6.5k citations indexed

About

Alan M. Rapoport is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Alan M. Rapoport has authored 200 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 180 papers in Psychiatry and Mental health, 116 papers in Pathology and Forensic Medicine and 75 papers in Physiology. Recurrent topics in Alan M. Rapoport's work include Migraine and Headache Studies (180 papers), Trigeminal Neuralgia and Treatments (97 papers) and Sympathectomy and Hyperhidrosis Treatments (72 papers). Alan M. Rapoport is often cited by papers focused on Migraine and Headache Studies (180 papers), Trigeminal Neuralgia and Treatments (97 papers) and Sympathectomy and Hyperhidrosis Treatments (72 papers). Alan M. Rapoport collaborates with scholars based in United States, Brazil and Greece. Alan M. Rapoport's co-authors include Fred D. Sheftell, Stewart J. Tepper, Marcelo E. Bigal, Richard B. Lipton, B. Lee Peterlin, Stephen D. Silberstein, Joel R. Saper, Sarah Walter, Randall E. Weeks and David W. Dodick and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and The Lancet Neurology.

In The Last Decade

Alan M. Rapoport

194 papers receiving 6.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan M. Rapoport United States 41 5.6k 3.4k 2.5k 543 539 200 6.5k
Peer Tfelt‐Hansen Denmark 42 5.8k 1.0× 3.3k 0.9× 2.6k 1.0× 615 1.1× 646 1.2× 195 6.8k
Mattias Linde Norway 47 5.9k 1.0× 2.9k 0.8× 1.8k 0.7× 612 1.1× 590 1.1× 125 6.9k
Stewart J. Tepper United States 47 7.8k 1.4× 4.9k 1.4× 3.0k 1.2× 858 1.6× 852 1.6× 286 9.3k
Antoinette MaassenVanDenBrink Netherlands 45 4.9k 0.9× 2.6k 0.8× 1.8k 0.7× 663 1.2× 580 1.1× 222 6.9k
Joel R. Saper United States 42 5.4k 1.0× 3.4k 1.0× 2.8k 1.1× 673 1.2× 649 1.2× 119 6.5k
Merle L. Diamond United States 27 5.1k 0.9× 3.1k 0.9× 1.9k 0.7× 367 0.7× 561 1.0× 52 5.6k
Julio Pascual Spain 45 6.2k 1.1× 3.8k 1.1× 2.5k 1.0× 554 1.0× 885 1.6× 280 8.2k
Seymour Diamond United States 29 4.5k 0.8× 2.6k 0.8× 1.8k 0.7× 348 0.6× 568 1.1× 160 5.4k
Charly Gaul Germany 40 3.5k 0.6× 2.3k 0.7× 1.6k 0.6× 656 1.2× 423 0.8× 223 5.2k
Patricia Pozo‐Rosich Spain 37 4.1k 0.7× 2.3k 0.7× 1.3k 0.5× 598 1.1× 380 0.7× 206 5.2k

Countries citing papers authored by Alan M. Rapoport

Since Specialization
Citations

This map shows the geographic impact of Alan M. Rapoport's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan M. Rapoport with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan M. Rapoport more than expected).

Fields of papers citing papers by Alan M. Rapoport

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan M. Rapoport. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan M. Rapoport. The network helps show where Alan M. Rapoport may publish in the future.

Co-authorship network of co-authors of Alan M. Rapoport

This figure shows the co-authorship network connecting the top 25 collaborators of Alan M. Rapoport. A scholar is included among the top collaborators of Alan M. Rapoport based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan M. Rapoport. Alan M. Rapoport is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mitsikostas, Dimos D., Christian Waeber, Margarita Sánchez del Río, et al.. (2023). The 5-HT1F receptor as the target of ditans in migraine — from bench to bedside. Nature Reviews Neurology. 19(8). 489–505. 14 indexed citations
3.
4.
5.
Landy, Stephen H., Sagar Munjal, Elimor Brand‐Schieber, & Alan M. Rapoport. (2018). Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study. The Journal of Headache and Pain. 19(1). 69–69. 15 indexed citations
6.
Rapoport, Alan M., et al.. (2018). CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine. Drugs. 78(9). 913–928. 23 indexed citations
7.
Silberstein, Stephen D., et al.. (2017). The emerging role of gammaCore® in the management of cluster headache: expert panel recommendations.. PubMed. 23(17 Suppl). S326–S333. 4 indexed citations
8.
Özge, Aynur, Noemi Faedda, Ishaq Abu‐Arafeh, et al.. (2017). Experts’ opinion about the primary headache diagnostic criteria of the ICHD-3rd edition beta in children and adolescents. The Journal of Headache and Pain. 18(1). 109–109. 51 indexed citations
9.
Tepper, Stewart J., et al.. (2017). New treatments for headache. Neurological Sciences. 38(S1). 145–156. 5 indexed citations
10.
Schuster, Nathaniel M. & Alan M. Rapoport. (2016). New strategies for the treatment and prevention of primary headache disorders. Nature Reviews Neurology. 12(11). 635–650. 68 indexed citations
11.
Rapoport, Alan M.. (2012). Acute Treatment of Migraine: Established and Emerging Therapies. Headache The Journal of Head and Face Pain. 52(s2). 60–64. 8 indexed citations
12.
Peterlin, B. Lee, Andrea Rosso, Alan M. Rapoport, & I Scher. (2009). Obesity and Migraine: The Effect of Age, Gender and Adipose Tissue Distribution. Headache The Journal of Head and Face Pain. 50(1). 52–62. 125 indexed citations
13.
Hargreaves, Richard, et al.. (2009). Ten Years of Rizatriptan: From Development to Clinical Science and Future Directions. Headache The Journal of Head and Face Pain. 49(s1). S3–20. 14 indexed citations
14.
Peterlin, B. Lee, Alan M. Rapoport, & Tobias Kurth. (2009). Migraine and Obesity: Epidemiology, Mechanisms, and Implications. Headache The Journal of Head and Face Pain. 50(4). 631–648. 104 indexed citations
15.
Rapoport, Alan M., et al.. (2009). Zolmitriptan Nasal Spray in the Acute Treatment of Cluster Headache: A Meta‐Analysis of Two Studies. Headache The Journal of Head and Face Pain. 49(9). 1315–1323. 22 indexed citations
16.
Bigal, Marcelo E., Richard B. Lipton, Herbert G. Markley, et al.. (2008). Comprehensive Review of Headache Medicine.
17.
Bigal, Marcelo E., Alan M. Rapoport, Fred D. Sheftell, Deborah Tepper, & Stewart J. Tepper. (2008). Memantine in the Preventive Treatment of Refractory Migraine. Headache The Journal of Head and Face Pain. 48(9). 1337–1342. 84 indexed citations
18.
Tepper, Stewart J., Marcelo E. Bigal, Fred D. Sheftell, & Alan M. Rapoport. (2004). Botulinum Neurotoxin Type A in the Preventive Treatment of Refractory Headache: A Review of 100 Consecutive Cases. Headache The Journal of Head and Face Pain. 44(8). 794–800. 27 indexed citations
19.
Tepper, SJ, FD Sheftell, & Alan M. Rapoport. (2000). Evidence-Based Guidelines for Migraine Headache. Journal watch. 2000. 8 indexed citations
20.
Dahlöf, Carl, Alan M. Rapoport, Fred D. Sheftell, & Christopher R. Lines. (1999). Rizatriptan in the treatment of migraine. Clinical Therapeutics. 21(11). 1823–1836. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peer Tfelt‐Hansen Breakdown of academic impact, for papers by Mattias Linde Breakdown of academic impact, for papers by Stewart J. Tepper Breakdown of academic impact, for papers by Antoinette MaassenVanDenBrink Breakdown of academic impact, for papers by Joel R. Saper Breakdown of academic impact, for papers by Merle L. Diamond Breakdown of academic impact, for papers by Julio Pascual Breakdown of academic impact, for papers by Seymour Diamond Breakdown of academic impact, for papers by Charly Gaul Breakdown of academic impact, for papers by Patricia Pozo‐Rosich
Rankless by CCL
2026